Alzheimer's disease (AD) is the most common progressive neurodegenerative disease
worldwide, but its cause remains unclear. Although a few drugs can provide temporary and …

Age is the strongest risk factor for Alzheimer's disease (AD). In recent years, the relationship
between aging and AD has been widely studied, with anti-aging therapeutics as the …

Background: Mesenchymal stem cells (MSCs)-derived extracellular vesicles (EVs) have
been reported to exhibit therapeutic effects in various animal models of neurological …

Alzheimer's disease (AD) is the most prevalent neurodegenerative disease with cognitive
decline and behavioral dysfunction. AD will become a global public health concern due to its …

Abstract Alzheimer's disease (AD), a progressive dementia, is one of the world's most
dangerous and debilitating diseases. Clinical trial results of amyloid-β (Aβ) and tau …

Excitatory (E) and inhibitory (I) balance of neural network activity is essential for normal brain
function and of particular importance to memory. Disturbance of E/I balance contributes to …

Neurodegenerative diseases called tauopathies, such as Alzheimer's disease (AD),
frontotemporal dementia, progressive supranuclear palsy, and Parkinson's disease, among …

Alzheimer's disease (AD) is a highly complex neurodegenerative disorder and the current
treatment strategies are largely ineffective thereby leading to irreversible and progressive …

As the size of the population aged 65 and older continues to grow, the incidence and
mortality rates of Alzheimer's disease (AD) are increasing annually. Unfortunately, current …

Dementia currently affects more than 55 million people worldwide, and scientists predict that
this number will continue to rise. The most common form is Alzheimer's disease (AD), which …